SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced it entered into a $15 million common ...
But the FDA could once again pull their products from the market. It all comes down to whether or not the agency keeps branded GLP-1 medicines on its shortage list. At the moment ... Compounded drugs ...
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.